Overall survival curves of G-CSF group (solid line) and | Download Scientific Diagram
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma | Journal for ImmunoTherapy of Cancer
Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2/signal transducer and activator of transcription 3 in ovarian cancer | British Journal of Cancer
Frontiers | GM-CSF: A Double-Edged Sword in Cancer Immunotherapy
Overall survival and risk of second malignancies with cancer chemotherapy and G-CSF support - Annals of Oncology
Neutrophils, G‐CSF and their contribution to breast cancer metastasis - Mouchemore - 2018 - The FEBS Journal - Wiley Online Library
JCM | Free Full-Text | Real-World Incidence of Febrile Neutropenia among Patients Treated with Single-Agent Amrubicin: Necessity of the Primary Prophylactic Administration of Granulocyte Colony-Stimulating Factor
Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review - ScienceDirect
Complications following novel therapies for non‐small cell lung cancer - Skribek - 2022 - Journal of Internal Medicine - Wiley Online Library
5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study - The Lancet Oncology
Immunoglobulin and granulocyte-colony stimulating factor affecting infection and hematopoietic reconstruction in allogeneic hematopoietic stem cell transplantation | Chinese Medical Journal
Prophylactic granulocyte-colony stimulating factor in patients with lung neuroendocrine carcinoma receiving platinum agents plus etoposide - ScienceDirect
Cells | Free Full-Text | Role of NRF2 in Lung Cancer
Pharmaceuticals | Free Full-Text | Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing
Lung cancer - The Lancet
Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial | BMC Cancer | Full Text
Prevention of febrile neutropenia: use of granulocyte colony-stimulating factors | British Journal of Cancer
Effects of primary granulocyte‑colony stimulating factor prophylaxis on the incidence of febrile neutropenia in patients with
Combination regimen of granulocyte colony-stimulating factor and recombinant human thrombopoietin improves the curative effect on elderly patients with leukemia through inducing pyroptosis and ferroptosis of leukemia cells | Cancer Gene Therapy
Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial - Lung Cancer
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
Frontiers | G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets
